These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: [Reversibility in perfusion scintigraphy after myocardial infarct: a comparison between the protocol of single-day rest-stress with 99mTc sestamibi and reinjection with thallium-201]. Author: Ferreira J, Gil VM, Ventosa A, Calqueiro J, Seabra-Gomes R. Journal: Rev Port Cardiol; 1993 Dec; 12(12):1013-21, 999. PubMed ID: 8117454. Abstract: OBJECTIVE: To compare thallium-201 stress-reinjection SPECT (TL) and single-day rest-stress 99mTc-sestamibi SPECT (MIBI) for detection of reversibility of perfusion defects after Q-wave myocardial infarction. DESIGN: Prospective study with the two scintigraphic methods. PATIENTS: We studied 31 patients with previous Q-wave myocardial infarction referred for assessment of myocardial viability. METHODS: Patients were studied with thallium-201 stress-reinjection SPECT and single-day rest-stress 99mTc-sestamibi SPECT. Tracer uptake was classified in a 0 to 4 intensity scale in each of 13 myocardial segments. RESULTS: Segmental comparison indicated that the identification of perfusion defects was similar by the two methods. Some reversibility was present in 51% of TL perfusion defects and in 26% of MIBI perfusion defects (p < 0.001). Twenty-seven percent of fixed perfusion defects in MIBI showed some reversibility by TL, but only 8% of the fixed perfusion defects by TL were reversible by MIBI (p < 0.001). In infarct-related perfusion defects, TL showed reversibility in 46% and MIBI in 22% (p < 0.001). TL detected reversibility in 84% of patients and MIBI in 48% (p = 0.007). CONCLUSIONS: Although the two methods were similar for perfusion defects identification, the present study suggests that thallium-201 reinjection is superior to single-day rest-stress 99mTc-sestamibi for the detection of reversibility. Clinical relevance of these differences, as a marker of viability, requires further evaluation of these patients after successful revascularization.[Abstract] [Full Text] [Related] [New Search]